LaBarre Michael J.'s Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Oct 16, 2024
- Accession no.
- 0001415889-24-025233
- Filed
- Oct 16, 2024
- Trade date
- Oct 15-16, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.07M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LaBarre Michael J.CIK 0001507174 | Officer (SVP, CHIEF TECHNICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | MOption exerciseAcquired | +5,509 | $16.65 | +$91,724.85 | 179,265 | Direct | |
| Oct 15, 2024 | Common Stock | MOption exerciseAcquired | +4,491 | $19.98 | +$89,730.18 | 183,756 | Direct | |
| Oct 15, 2024 | Common Stock | SSaleDisposed | −9,923 | $53.74 | −$533,262.02 | 173,833 | Direct | |
| Oct 15, 2024 | Common Stock | SSaleDisposed | −77 | $54.25 | −$4,177.25 | 173,756 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $19.98 | +$199,800 | 183,756 | Direct | |
| Oct 16, 2024 | Common Stock | SSaleDisposed | −10,000 | $53.26 | −$532,600 | 173,756 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | MOption exerciseDisposed | −5,509 | $0.00 | $0 | 6,352 | Direct | |
| Oct 15, 2024 | Common Stock | MOption exerciseDisposed | −4,491 | $0.00 | $0 | 36,608 | Direct | |
| Oct 16, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 26,608 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.